Zdrowie i gospodarka · 07/12/2010
FDA Clears AUGMENTIN Drug Products for Sale, Citing Lack of Safety or Effectiveness Concerns
The FDA has determined that AUGMENTIN drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving ANDA applications that refer to these products.